Publications for Stina Axelsson
Co-author map based on ISI articles 2007-

Publications mentioned in social media 5 times*

Keywords

trial treatment t secretion recent-onset placebo patients insulin immune iii gad-alum gad(65) doses diabetes cytokine children cells c-peptide 30 15

Journal Articles

Stina Axelsson, Mikael Cheramy, Linda Åkerman, Mikael Pihl, Johnny Ludvigsson and Rosaura Casas
  Cellular and Humoral Immune responses in Type 1 Diabetic patients participating in a Phase III GAD-alum Intervention Trial
  Diabetes Care, 2013, 36(11), 3418-3424.
   Fulltext  PDF  

Mikael Pihl, Linda Åkerman, Stina Axelsson, Mikael Chéramy, Maria Hjorth, R. Mallone, Johnny Ludvigsson and Rosaura Casas
  Regulatory T cell phenotype and function 4 years after GAD–alum treatment in children with type 1 diabetes
 
Altmetric usage: 1

  Clinical and Experimental Immunology, 2013, 172(3), 394-402.
   Fulltext  PDF  

Stina Axelsson, Maria Hjorth, Johnny Ludvigsson and Rosaura Casas
  Decreased GAD(65) -specific Th1/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum.
 
Altmetric usage: 1

  Diabetic Medicine, 2012, 29(10), 1272-1278.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Stina Axelsson, Mikael Chéramy, Maria Hjorth, Mikael Pihl, Linda Åkerman, Emanuela Martinuzzi, Roberto Mallone, Johnny Ludvigsson and Rosaura Casas
  Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
 
Altmetric usage: 2

  PLoS ONE, 2011, 6(12), .
   Fulltext  PDF  
 Web of Science® Times Cited: 10

Johnny Ludvigsson, Maria Hjorth, Mikael Chéramy, Stina Axelsson, Mikael Pihl, G Forsander, N-O Nilsson, B-O Samuelsson, T Wood, J Aman, E Ortqvist and Rosaura Casas
  Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
  DIABETOLOGIA, 2011, 54(3), 634-640.
   Fulltext  PDF  
 Web of Science® Times Cited: 25

Maria Hjorth, Stina Axelsson, Anna Ryden, Maria Faresjo, Johnny Ludvigsson and Rosaura Casas
  GAD-alum treatment induces GAD(65)-specific CD4(+)CD25(high)FOXP3(+) cells in type 1 diabetic patients
  CLINICAL IMMUNOLOGY, 2011, 138(1), 117-126.
 Web of Science® Times Cited: 15

Stina Axelsson, Maria Hjorth, Linda Åkerman, Johnny Ludvigsson and Rosaura Casas
  Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65)
  Diabetes/Metabolism Research Reviews, 2010, 26(7), 559-568.
 Web of Science® Times Cited: 12

Johnny Ludvigsson, Maria Faresjö, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl, Outi Vaarala, Gun Forsander, Sten Ivarsson, Calle Johansson, Agne Lindh, NO Nilsson, Jan Åman, Eva Örtqvist, Peter Zerhouni and Rosaura Casas
  GAD treatment and insulin secretion in recent-onset type 1 diabetes
 
Altmetric usage: 1

  New England Journal of Medicine, 2008, 359(18), 1909-1920.
 Web of Science® Times Cited: 224

Maria Hedman Hjorth, Maria Faresjö, Stina Axelsson, Johnny Ludvigsson and Rosaura Casas
  Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children
  Clinical and Experimental Immunology, 2008, 153(3), 360-368.
   Fulltext  PDF  
 Web of Science® Times Cited: 10

Stina Axelsson, Maria Faresjö, Maria Hedman, Johnny Ludvigsson and Rosaura Casas
  Cryopreserved peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children
  Cryobiology, 2008, 57(3), 201-208.
 Web of Science® Times Cited: 12

Conference Articles

E Martinuzzi, M C Gagnerault, S Fourlanos, L Harrison, Stina Axelsson, Mikael Chéramy, Johnny Ludvigsson, Rosaura Casas and R Mallone
  Why are the benefits of vaccinations in the helping of beta-cellular antigenes in type 1 diabetes so limited? An analysis of linked immunological biomarkers in DIABETES and METABOLISM, vol 38, issue 2, pp A5-A5
  DIABETES and METABOLISM, 2012.


Rosaura Casas, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl and Johnny Ludvigsson
  Specific immunomodulatory effect of GAD(65) in type 1 diabetics
  in DIABETOLOGIA, vol 52, 2009.


Maria Hjorth, Stina Axelsson, Johnny Ludvigsson and Rosaura Casas
  GAD-alum treatment induces GAD-specific FOXP3+ cells in type 1 diabetic children
  in DIABETOLOGIA, vol 52, 2009.


Stina Axelsson, Maria Hjorth, L Akerman, Johnny Ludvigsson and Rosaura Casas
  Treatment with alum-formulated GAD65 in type 1 diabetic children results in early induction of Th2 responses
  in DIABETOLOGIA, vol 52, 2009.


Ph.D. Theses

Stina Axelsson
  GAD65 An Immunomodulator in Type 1 Diabetes
  2012.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.